| The role of neutrophils in thrombosis S Kapoor, A Opneja, L Nayak Thrombosis research 170, 87-96, 2018 | 174 | 2018 |
| Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing A Opneja, S Kapoor, EX Stavrou Thrombosis research 179, 56-63, 2019 | 159 | 2019 |
| Monitoring DOACs with a novel dielectric microsensor: a clinical study D Maji, A Opneja, MA Suster, KL Bane, BM Wilson, P Mohseni, ... Thrombosis and haemostasis 121 (01), 058-069, 2021 | 13 | 2021 |
| Prior history of venous thromboembolism is a significant risk factor for recurrence of thrombosis after cancer diagnosis S Kapoor, A Opneja, J Gollamudi, LV Nayak Blood 136, 32-33, 2020 | 7 | 2020 |
| Patterns of long-term cancer survivorship care in a National Cancer Institute-designated Comprehensive Cancer Center K Miller, R Mehta, J Abraham, A Opneja, RK Jain American Journal of Clinical Oncology 40 (6), 639-643, 2017 | 7 | 2017 |
| Unusual paraneoplastic presentation of cholangiocarcinoma A Opneja, S Mahajan, S Kapoor, S Marur, SH Yang, R Manno Case Reports in Medicine 2015 (1), 806835, 2015 | 6 | 2015 |
| Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the … A Opneja, G Cioffi, A Alahmadi, N Jones, TY Tang, N Patil, DL Bajor, ... Cancer Medicine 10 (13), 4397-4404, 2021 | 3 | 2021 |
| Sub-optimal detection of left ventricular thrombi with 2D transthoracic echocardiography compared to cardiac magnetic resonance despite the use of contrast echocardiography N Garg, JC Lopez-Mattei, H Ibrahim, A Opneja, D Shah, WA Zoghbi Circulation 126 (suppl_21), A13052-A13052, 2012 | 3 | 2012 |
| Primary liver angiosarcoma and factors associated with improved outcomes: An analysis of the National Cancer Database. P Jain, G Cioffi, N Patil, A Opneja, A Alahmadi, DL Bajor, JN Saltzman, ... Journal of Clinical Oncology 38 (4_suppl), 498-498, 2020 | 1 | 2020 |
| The impact of sorafenib on the treatment and survival of advanced hepatocellular carcinoma (HCC): Analysis of the National Cancer Database (NCDB) from 2004 to 2014. A Opneja, G Cioffi, A Alahmadi, N Patil, DL Bajor, JN Saltzman, ... Journal of Clinical Oncology 37 (15_suppl), e15682-e15682, 2019 | 1 | 2019 |
| Impact of facility type, insurance status, and income on use of single agent chemotherapy (SACT) for advanced hepatocellular carcinoma (AHCC): Analysis of National Cancer … RT Lee, G Cioffi, A Opneja, A Alahmadi, N Patil, N Jones, DL Bajor, ... Journal of Clinical Oncology 38 (4_suppl), 504-504, 2020 | | 2020 |
| The effect of race on adherence to NCCN Guidelines for patients with biliary tract cancers (BTC) after surgery. A Alahmadi, G Cioffi, A Opneja, N Patil, DL Bajor, JN Saltzman, ... Journal of Clinical Oncology 37 (15_suppl), e15686-e15686, 2019 | | 2019 |
| Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study A Opneja, D Maji, P Mohseni, MA Suster, EX Stavrou Blood 132, 988, 2018 | | 2018 |
| Patterns of metastases, treatment (tx), and outcomes in bone predominant (BP) metastatic urothelial carcinoma (mUC). AA Nelson, A Opneja, BG Nezami, LE Ponsky, MD Wright, P Mergler, ... Journal of Clinical Oncology 36 (15_suppl), e16523-e16523, 2018 | | 2018 |
| Outcomes in bone predominant (BP) urothelial carcinoma (UC). AA Nelson, A Opneja, BG Nezami, P Fu, S Dawsey, MD Wright, C Eitman, ... Journal of Clinical Oncology 36 (6_suppl), 441-441, 2018 | | 2018 |
| Implantable intravenous devices (“ports”) as a survivorship issue. A Opneja, A Rout, J Abraham, G Gill, KD Miller Journal of Clinical Oncology 34 (3_suppl), 9-9, 2016 | | 2016 |
| Length of mediports use in patients treated with curative intent. A Opneja, PG Tripathi, M Oktem, KD Miller Journal of Clinical Oncology 33 (15_suppl), e17742-e17742, 2015 | | 2015 |
| Clinical focus and and funding characteristics of cancer trials registered in ClinicalTrials. gov. S Hasan, A Sinha, R Anand, A Opneja, A Sivaraman, S Bhandari, ... Journal of Clinical Oncology 33 (15_suppl), e12631-e12631, 2015 | | 2015 |
| Platelet reactivity in patients with advanced stage adenocarcinoma and healthy controls. A Basu, R Gosain, A Opneja, KD Miller Journal of Clinical Oncology 33 (15_suppl), e22003-e22003, 2015 | | 2015 |
| Oncologists' opinions about second opinions in cancer care. KD Miller, A Opneja, PG Tripathi Journal of Clinical Oncology 33 (15_suppl), e17726-e17726, 2015 | | 2015 |
